This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $4,004.68 and a period of performance ending on May 22, 2025. The contract is not set aside for a specific socioeconomic program. AmerisourceBergen Drug Corp is the prime contractor and holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $19,275.02 and a period of performance through April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $5,005.85 and a period of performance ending on June 26, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $13,944.13 and an ultimate completion date of September 13, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network to support various government agencies and healthcare programs....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication, with an ultimate completion date of June 24, 2025 and a ceiling value of $30,938.66. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. The contract has a ceiling value of $6,007.02 and is a Firm Fixed Price Delivery Order with a completion date of July 10, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is the prime...
This is a $28,167.35 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has an ultimate completion date of July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $17,438.11 and a period of performance through April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication, with a ceiling value of $19,785.84 and a performance period ending on May 20, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product, with a ceiling value of $1,001.17. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...